Ajinomoto Bio Pharma Services
About Ajinomoto Bio Pharma Services
At Ajinomoto Bio-Pharma Services, our mission is to help improve the health of humankind. Our ultimate goal is to provide adaptive solutions, responsive service, trusted partnerships and peace of mind to our customers. Through innovation, accountability, compliance, communication and teamwork, we take pride in knowing our efforts are helping countless patients for years to come.
Stock Symbol:
AJINY
Stock Exchange:
OTCMKTS
Aji Bio-Pharma Animated Overview
77 articles about Ajinomoto Bio Pharma Services
-
Althea Technologies, Inc. Names Karen Daniels as President of the Company's Bio-Services Division
7/17/2007
-
Althea Technologies, Inc. Contracted by GeoVax Labs Inc. to Produce a Phase 2 AIDS Vaccine
6/20/2007
-
Althea Technologies, Inc.' Manufacturing Capacity Grows Through New Facility Construction
5/3/2007
-
Althea Technologies, Inc. Repeats as One of the "Best Places to Work" in San Diego
3/13/2007
-
Althea Technologies, Inc. Announces The Development Of A Diagnostic Capable Of Differentiating Multiple Forms Of Childhood Cancer
2/20/2007
-
Althea Technologies, Inc. And Blueshift Biotechnologies Combine Technologies For High Throughput, Gene Expression Screening
2/1/2007
-
Althea Technologies, Inc. Closes $23 Million Financing
1/9/2007
-
Althea Technologies, Inc. To Present At The Upcoming BIOCOM Investors Conference In San Diego
11/8/2006
-
Althea Technologies, Inc. Selected By Deloitte & Touche As One Of San Diego's Fastest Growing Technology Companies For The Third Year
10/3/2006
-
Althea Technologies, Inc. Selected As One Of The Best Places To Work in San Diego, California By Employers Group And San Diego Magazine
8/31/2006
-
Althea Technologies, Inc. Awarded Advanced BioScience Laboratories, Inc. Contract To Produce DNA-Based HIV Vaccine For U.S. National Institute of Allergy, Infectious Disease
8/29/2006
-
Althea Technologies, Inc. To Manufacture Altus Pharmaceuticals Inc.'s ALTU-238 Human Growth Hormone For Phase III Studies
8/22/2006
-
Althea Technologies, Inc. Contracted By PowderMed Ltd To Produce Innovative Plasmid DNA-Based Influenza Vaccine
6/20/2006
-
Althea Technologies, Inc. Receives The Corporate UCSD Athena Pinnacle Award
4/27/2006
-
Althea Technologies, Inc. Announces The Appointment Of Chris Duffy As VP Of Operations And Roy Musil As VP Of Quality And Regulatory Affairs
3/29/2006
-
Althea Technologies, Inc. Announces cGMP Facilities Expansion
1/18/2006
-
Althea Technologies, Inc. Introduces Time Saving Assay For Predicting Carcinogenicity Using PCR-Based Gene Expression Profiling
11/8/2005